Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
7.79%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth7.79%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
2.9
-108.74%
60%
—
-100.00%
Never
—
5 Years
Score2.9
Net Growth-108.74%
Net Trend60%
Net Income Consistency—
Rev Growth-100.00%
Rev TrendNever
Revenue Consistency—
Cardiol Therapeutics Inc Class A fundamental performance
Between 2020 and 2025, revenue declined from $ 78.76K to $ 0.00 and net income went from -$ 16M to -$ 33M. Revenue increased in 0 of those 5 years; net income in 3.
Cardiol Therapeutics Inc Class A currently holds a 5-year HDB Score of 2.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.52 | — |
1 Year2025-08-12 | $ 1.13 | 34.51% |
5 Years2021-08-12 | $ 2.66 | -42.86% |
All Time2019-01-15 | $ 3.74 | -59.38% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-01-15 |
|---|---|---|---|---|
| Price | $ 1.52 | $ 1.13 | $ 2.66 | $ 3.74 |
| Return | — | 34.51% | -42.86% | -59.38% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 33M | $ 21M |
| 2024 | $ 0.00 | -$ 36M | $ 30M |
| 2023 | $ 0.00 | -$ 21M | $ 34M |
| 2022 | $ 0.00 | -$ 22M | $ 43M |
| 2021 | $ 62.27K | -$ 25M | $ 83M |
| 2020 | $ 78.76K | -$ 16M | $ 14M |
| IPO2019 | $ 0.00 | -$ 10M | $ 6M |
Explore beyond CRDL
You're looking at Cardiol Therapeutics Inc Class A. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
